Active, Not Recruiting
A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
NCT04808245
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +8 more
- Locations
-
- Department of Neurology and Polyclinic, Universitiy Clinic Heidelberg Heidelberg, Baden-Wurttemberg, Germany
- University Medical Center Mannheim, Department of Neurology Mannheim, Baden-Wurttemberg, Germany
- University Clinic Tuebingen, Neurological Clinic, Department of Neurology Tübingen, Baden-Wurttemberg, Germany
- Dr. Senckenberg Institute for Neurooncology, University Hospital Frankfurt Frankfurt am Main, Hesse, Germany